Cargando…

Serum anti-p53 antibody as a tumour marker for colorectal cancer screening

A 60-year-old Japanese man presented to our hospital for further investigation of an elevated serum anti-p53 antibody level. He was diagnosed with colon cancer and the tumour was surgically resected. Histological diagnosis of advanced colon cancer without lymph node involvement or distant metastasis...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwamuro, Masaya, Kawai, Yoshinari, Matsumoto, Tomoko, Uda, Masashi, Okada, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531133/
https://www.ncbi.nlm.nih.gov/pubmed/26284124
http://dx.doi.org/10.3332/ecancer.2015.560
Descripción
Sumario:A 60-year-old Japanese man presented to our hospital for further investigation of an elevated serum anti-p53 antibody level. He was diagnosed with colon cancer and the tumour was surgically resected. Histological diagnosis of advanced colon cancer without lymph node involvement or distant metastasis was made. It was noteworthy that both serum carcinoembryonic antigen (CEA) and a fecal occult blood test that were performed preoperatively were non-diagnostic. This case highlights the potential usefulness of serum anti-p53 antibody tests for detection of colorectal cancers. Moreover, sequential changes in the anti-p53 antibody levels after curative resection were observed.